# Grifols

Source: https://onco.cc/companies/grifols/  
OnCo record `grifols` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Grifols is the Catalan plasma-medicines group founded in 1909, whose immunoglobulins, albumin and clotting factors are used in supportive cancer care, and which has led phase 3 trials in cancer-related settings.

## Summary

Grifols, headquartered in Sant Cugat del Vallès near Barcelona and founded in 1909, is one of the three largest plasma-derived medicines companies, producing immunoglobulins used for infection prevention in blood cancers, albumin and coagulation factors, alongside diagnostics. Its US arms Grifols Therapeutics and Grifols Biologicals appear on ClinicalTrials.gov as lead sponsors of phase 3 trials in cancer-related settings.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Grifols Therapeutics LLC; Grifols Biologicals, LLC; Grifols S.A.
- Tags: ctgov-sponsor
- HQ: Sant Cugat del Vallès
- Type: pharma
- Website: https://www.grifols.com

## Sources

- Official website: https://www.grifols.com
- ClinicalTrials.gov: trials led by Grifols Therapeutics LLC: https://clinicaltrials.gov/search?lead=Grifols%20Therapeutics%20LLC
- Wikidata: https://www.wikidata.org/wiki/Q901262

## Connected records

- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/grifols.json